메뉴 건너뛰기




Volumn 13, Issue 7, 2012, Pages 3213-3218

Comparison of WHO and RECIST criteria for evaluation of clinical response to chemotherapy in patients with advanced breast cancer

Author keywords

Breast cancer; Clinical response; RECIST; RECIST breast; Response criteria; WHO

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; CLINICAL TRIAL (TOPIC); FEMALE; HUMAN; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 84873578190     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3213     Document Type: Article
Times cited : (38)

References (41)
  • 2
    • 54449090420 scopus 로고    scopus 로고
    • Across generations: cancer treatment in developing countries
    • Aziz Z (2008). Across generations: cancer treatment in developing countries. J Clin Oncol, 26, 4990-1.
    • (2008) J Clin Oncol , vol.26 , pp. 4990-4991
    • Aziz, Z.1
  • 3
    • 0642347622 scopus 로고    scopus 로고
    • The effect of tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27
    • Bear HD, Anderson S, Brown A, et al. (2003). The effect of tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol, 21, 4165-74.
    • (2003) J Clin Oncol , vol.21 , pp. 4165-4174
    • Bear, H.D.1    Anderson, S.2    Brown, A.3
  • 4
    • 33646391234 scopus 로고    scopus 로고
    • Pakistan - country profile of cancer and cancer control 1995-2004
    • Bhurgri Y, Bhurgri A, Nishter S, et al. (2006). Pakistan - country profile of cancer and cancer control 1995-2004. J Pak Med Assoc, 56, 124-30.
    • (2006) J Pak Med Assoc , vol.56 , pp. 124-130
    • Bhurgri, Y.1    Bhurgri, A.2    Nishter, S.3
  • 5
    • 0031972858 scopus 로고    scopus 로고
    • Primary chemotherapy in operable breast cancer: Eight year experience at Milan Cancer Institute
    • Bonadonna G, Valagussa P, Brambilla C, et al. (1998). Primary chemotherapy in operable breast cancer: Eight year experience at Milan Cancer Institute. J Clin Oncol, 16, 93-100
    • (1998) J Clin Oncol , vol.16 , pp. 93-100
    • Bonadonna, G.1    Valagussa, P.2    Brambilla, C.3
  • 6
    • 84856091199 scopus 로고    scopus 로고
    • Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
    • 1471-2407/12/
    • Cao MD, Giskeodegard GF, Bathen TF et al. (2012). Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer:12:39 available at http://www.biomedcentral.com/1471-2407/12/39.
    • (2012) BMC Cancer:12:39 available at , pp. 39
    • Cao, M.D.1    Giskeodegard, G.F.2    Bathen, T.F.3
  • 7
    • 34548379045 scopus 로고    scopus 로고
    • Assessment of tumor response in malignant pleural mesothelioma
    • Ceresoli GL, Chiti A, Zucali PA, et al. (2007). Assessment of tumor response in malignant pleural mesothelioma. Cancer Treat Rev, 33, 533-41.
    • (2007) Cancer Treat Rev , vol.33 , pp. 533-541
    • Ceresoli, G.L.1    Chiti, A.2    Zucali, P.A.3
  • 8
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
    • Cheson BD, Horning SJ, Coiffier B, et al. (1999). Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol, 17, 1244-53.
    • (1999) J Clin Oncol , vol.17 , pp. 1244-1253
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 9
    • 33947496614 scopus 로고    scopus 로고
    • Revised response criteria for malignant lymphoma
    • Cheson BD, Pfistner B, Juweid ME, et al. (2007). Revised response criteria for malignant lymphoma. J Clin Oncol, 25, 579-86
    • (2007) J Clin Oncol , vol.25 , pp. 579-586
    • Cheson, B.D.1    Pfistner, B.2    Juweid, M.E.3
  • 10
    • 16644389881 scopus 로고    scopus 로고
    • CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings
    • Choi H, Charnsangavej C, De Castro Faria S, et al. (2004). CT evaluation of the response of gastrointestinal stromal tumors after imatinib mesylate treatment: a quantitative analysis correlated with FDG PET findings. Am J Roentgenol, 183, 1619-28.
    • (2004) Am J Roentgenol , vol.183 , pp. 1619-1628
    • Choi, H.1    Charnsangavej, C.2    De Castro Faria, S.3
  • 11
    • 34249085905 scopus 로고    scopus 로고
    • Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria
    • Choi H, Charnsangavej C, Faria SC, et al. (2007). Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol, 25, 1753-9.
    • (2007) J Clin Oncol , vol.25 , pp. 1753-1759
    • Choi, H.1    Charnsangavej, C.2    Faria, S.C.3
  • 12
    • 0035884629 scopus 로고    scopus 로고
    • The Indian Scene
    • Chopra K (2001).The Indian Scene. J Clin Oncol, 19, 106-11.
    • (2001) J Clin Oncol , vol.19 , pp. 106-111
    • Chopra, K.1
  • 13
    • 83855160927 scopus 로고    scopus 로고
    • Comparison of tumor response by response evaluation criteria in solid tumors (RECIST) and modified RECIST in patients treated with Sorafenib for hepatocellular carcinoma
    • Edeline J, Boucher E, Rolland Y et al. (2012). Comparison of tumor response by response evaluation criteria in solid tumors (RECIST) and modified RECIST in patients treated with Sorafenib for hepatocellular carcinoma. Cancer, 118, 147-56.
    • (2012) Cancer , vol.118 , pp. 147-156
    • Edeline, J.1    Boucher, E.2    Rolland, Y.3
  • 14
    • 57849117384 scopus 로고    scopus 로고
    • New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)
    • Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009). New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer, 45, 228-47.
    • (2009) Eur J Cancer , vol.45 , pp. 228-247
    • Eisenhauer, E.A.1    Therasse, P.2    Bogaerts, J.3
  • 15
    • 0031982870 scopus 로고    scopus 로고
    • Clinical prognostic and predictive factors in operable breast cancer
    • Ellis P, Smith I, Ashley S, et al. (1998). Clinical prognostic and predictive factors in operable breast cancer. J Clin Oncol, 16, 107-14.
    • (1998) J Clin Oncol , vol.16 , pp. 107-114
    • Ellis, P.1    Smith, I.2    Ashley, S.3
  • 16
    • 33644909639 scopus 로고    scopus 로고
    • Breast Cancer in Limited Resource Countries: Treatment and Allocation of Resources
    • Eniu A, Carlson RW, Aziz Z et al. (2008). Breast Cancer in Limited Resource Countries: Treatment and Allocation of Resources. The Breast, 12, 38-53.
    • (2008) The Breast , vol.12 , pp. 38-53
    • Eniu, A.1    Carlson, R.W.2    Aziz, Z.3
  • 17
    • 79960292266 scopus 로고    scopus 로고
    • Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib
    • Faivre S, Zappa M, Vilgrain V, et al. (2011). Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib. Clin Cancer Res, 17, 4504-12
    • (2011) Clin Cancer Res , vol.17 , pp. 4504-4512
    • Faivre, S.1    Zappa, M.2    Vilgrain, V.3
  • 18
    • 0035166497 scopus 로고    scopus 로고
    • Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease
    • Fiorentino C, Berruti A, Bottini A, et al. (2001). Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. Breast Cancer Res Treat, 69, 143-51.
    • (2001) Breast Cancer Res Treat , vol.69 , pp. 143-151
    • Fiorentino, C.1    Berruti, A.2    Bottini, A.3
  • 19
    • 0031926839 scopus 로고    scopus 로고
    • Effect of Preoperative Chemotherapy on the outcome of women with operable breast cancer
    • Fisher B, Bryant J, Wolmark N et al. (1998). Effect of Preoperative Chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol, 16, 2672-85.
    • (1998) J Clin Oncol , vol.16 , pp. 2672-2685
    • Fisher, B.1    Bryant, J.2    Wolmark, N.3
  • 20
    • 0030769452 scopus 로고    scopus 로고
    • Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma
    • Herrada J, Iyer RB, Atkinson EN, et al. (1997). Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res, 3, 1565-9.
    • (1997) Clin Cancer Res , vol.3 , pp. 1565-1569
    • Herrada, J.1    Iyer, R.B.2    Atkinson, E.N.3
  • 21
    • 79955845255 scopus 로고    scopus 로고
    • Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence
    • Hutson TE (2011). Targeted therapies for the treatment of metastatic renal cell carcinoma: clinical evidence. Oncologist, 16, 14-22.
    • (2011) Oncologist , vol.16 , pp. 14-22
    • Hutson, T.E.1
  • 22
    • 0033577247 scopus 로고    scopus 로고
    • Measuring response in solid tumors: Unidimensional versus bidimensional measurement
    • James K, Eisenhauer E, Christian M et al. (1999). Measuring response in solid tumors: Unidimensional versus bidimensional measurement. J Natl Cancer Inst, 91, 523-8.
    • (1999) J Natl Cancer Inst , vol.91 , pp. 523-528
    • James, K.1    Eisenhauer, E.2    Christian, M.3
  • 23
    • 78650713802 scopus 로고    scopus 로고
    • Response to Neoadjuvant chemotherapy in patients with advanced breast cancer: A local hospital experience
    • Khokher S, Mahmood S, Khan SA (2010). Response to Neoadjuvant chemotherapy in patients with advanced breast cancer: A local hospital experience. Asian Pac J Cancer Prev, 11, 303-8.
    • (2010) Asian Pac J Cancer Prev , vol.11 , pp. 303-308
    • Khokher, S.1    Mahmood, S.2    Khan, S.A.3
  • 24
    • 84856289604 scopus 로고    scopus 로고
    • Response to Neoadjuvant chemotherapy in patients with advanced breast cancer: A local hospital experience
    • Khokher S, Mahmood S, Qureshi MU, Khan SA, Chaudhry NA (2011). Response to Neoadjuvant chemotherapy in patients with advanced breast cancer: A local hospital experience. Asian Pac J Cancer Prev, 12, 939-46.
    • (2011) Asian Pac J Cancer Prev , vol.12 , pp. 939-946
    • Khokher, S.1    Mahmood, S.2    Qureshi, M.U.3    Khan, S.A.4    Chaudhry, N.A.5
  • 25
    • 84866450881 scopus 로고    scopus 로고
    • Clinicopathologic profile of breast cancer patients in Pakistan: Ten years data of a local cancer hospital
    • Khokher S, Qureshi MU, Riaz M, Akhtar N, Saleem A (2012). Clinicopathologic profile of breast cancer patients in Pakistan: Ten years data of a local cancer hospital. Asian Pac J Cancer Prev, 13, 693-8.
    • (2012) Asian Pac J Cancer Prev , vol.13 , pp. 693-698
    • Khokher, S.1    Qureshi, M.U.2    Riaz, M.3    Akhtar, N.4    Saleem, A.5
  • 26
    • 0033050164 scopus 로고    scopus 로고
    • Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin based neoadjuvant chemotherapy
    • Kuerer HM, Newman LA, Smith TL, et al. (1999). Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin based neoadjuvant chemotherapy. J Clin Oncol, 17, 460-9.
    • (1999) J Clin Oncol , vol.17 , pp. 460-469
    • Kuerer, H.M.1    Newman, L.A.2    Smith, T.L.3
  • 28
    • 0642372937 scopus 로고    scopus 로고
    • Measuring response in solid tumors: comparison of RECIST and WHO response criteria
    • Park JO, Lee SI, Song SY, et al. (2003). Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol;33(10):533-7.
    • (2003) Jpn J Clin Oncol , vol.33 , Issue.10 , pp. 533-537
    • Park, J.O.1    Lee, S.I.2    Song, S.Y.3
  • 29
    • 58749085047 scopus 로고    scopus 로고
    • Changes and predivtive and prognostic value of the mitotic index. Ki-67, Cyclin D1 and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy
    • Penault-Llorca F, Abrial C, Raoelfils I, et al. (2008). Changes and predivtive and prognostic value of the mitotic index. Ki-67, Cyclin D1 and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy. The Oncologist, 13, 1235-45.
    • (2008) The Oncologist , vol.13 , pp. 1235-1245
    • Penault-Llorca, F.1    Abrial, C.2    Raoelfils, I.3
  • 30
    • 39149111633 scopus 로고    scopus 로고
    • Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
    • Rastogi P, Anderson SJ, Bear HD, et al. (2008). Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol, 26, 778-85.
    • (2008) J Clin Oncol , vol.26 , pp. 778-785
    • Rastogi, P.1    Anderson, S.J.2    Bear, H.D.3
  • 32
    • 18844457915 scopus 로고    scopus 로고
    • Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate
    • Shankar S, Van Sonnenberg E, Desai J, et al. (2005). Gastrointestinal stromal tumor: new nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate. Radiology, 235, 892-8.
    • (2005) Radiology , vol.235 , pp. 892-898
    • Shankar, S.1    Van Sonnenberg, E.2    Desai, J.3
  • 33
    • 33744486868 scopus 로고    scopus 로고
    • Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer
    • Sperber F, Weinstein Y, Sarid D, et al. (2006). Preoperative clinical, mammographic and sonographic assessment of neoadjuvant chemotherapy response in breast cancer. IMAJ, 8, 342-6.
    • (2006) IMAJ , vol.8 , pp. 342-346
    • Sperber, F.1    Weinstein, Y.2    Sarid, D.3
  • 34
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National cancer institute of United States, National cancer institute of Canada
    • Therasse P, Arbuck SG, Eisenhauer EA, et al. (2000). New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National cancer institute of United States, National cancer institute of Canada. J Natl Cancer Inst, 92, 205-16
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3
  • 35
    • 33646401788 scopus 로고    scopus 로고
    • RECIST revisited: a review of validation studies on tumor assessment
    • Therasse P, Eisenhauer EA, Verweij J (2006). RECIST revisited: a review of validation studies on tumor assessment. Eur J Cancer, 42, 1031-9.
    • (2006) Eur J Cancer , vol.42 , pp. 1031-1039
    • Therasse, P.1    Eisenhauer, E.A.2    Verweij, J.3
  • 36
    • 0036710115 scopus 로고    scopus 로고
    • Measuring the clinical response. What does it mean?
    • Therasse P (2002). Measuring the clinical response. What does it mean? Eur J Cancer, 38, 1817-23.
    • (2002) Eur J Cancer , vol.38 , pp. 1817-1823
    • Therasse, P.1
  • 37
    • 0347087214 scopus 로고    scopus 로고
    • Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma
    • Van Klaveren RJ, Aerts JG, de Bruin H, et al (2004). Inadequacy of the RECIST criteria for response evaluation in patients with malignant pleural mesothelioma. Lung Cancer, 43, 63-9.
    • (2004) Lung Cancer , vol.43 , pp. 63-69
    • Van Klaveren, R.J.1    Aerts, J.G.2    de Bruin, H.3
  • 38
    • 48949119494 scopus 로고    scopus 로고
    • Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast
    • Von Minckwitz G, Sinn HP, Raab G,et al. (2008). Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. Breast Cancer Res, 10, 30.
    • (2008) Breast Cancer Res , vol.10 , pp. 30
    • Von Minckwitz, G.1    Sinn, H.P.2    Raab, G.3
  • 39
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
    • Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009). From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med, 50, 122-50.
    • (2009) J Nucl Med , vol.50 , pp. 122-150
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 40
    • 0035751675 scopus 로고    scopus 로고
    • Preoperative chemotherapy in patients with operable breast cancer:nine year results from national surgical adjuvant breast and bowel project B-18J Natl
    • Wolmark N, Wang J, Mamounas E, et al. (2001). Preoperative chemotherapy in patients with operable breast cancer:nine year results from national surgical adjuvant breast and bowel project B-18J Natl. Cancer Inst Monogr, 30, 96-102.
    • (2001) Cancer Inst Monogr , vol.30 , pp. 96-102
    • Wolmark, N.1    Wang, J.2    Mamounas, E.3
  • 41
    • 39049184141 scopus 로고    scopus 로고
    • Epidemiology of breast cancer in Malaysia Asian pacific
    • Yip CH, Taib NAM, Mohamed I (2006). Epidemiology of breast cancer in Malaysia Asian pacific. J Cancer Prev, 7, 369-74.
    • (2006) J Cancer Prev , vol.7 , pp. 369-374
    • Yip, C.H.1    Taib, N.A.M.2    Mohamed, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.